Whalegun
Home

Regeneron Pharmaceuticals REGN paid Arnold & Porter Kaye Scholer $10K for lobbying in Q4 2022 · Copyright, Medicare

Trade details

Type
Lobbying report
Amount
$10,000
Quarter
Q4 2022
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
23/01/18

$440K on lobbying in 2022

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN paid Arnold & Porter Kaye Scholer $10K for lobbying in Q4 2022 · Copyright, Medicare | Whalegun